These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 62790)

  • 1. Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.
    Romualdez AG; Ward PA; Torikata T
    J Immunol; 1976 Nov; 117(5 Pt.2):1762-6. PubMed ID: 62790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
    Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
    Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Further studies on the C5-derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Prog Clin Biol Res; 1976; 9():65-71. PubMed ID: 193134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.
    Orr W; Varani J; Ward PA
    Am J Pathol; 1978 Nov; 93(2):405-22. PubMed ID: 568888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antileukotactic properties of tumor cells.
    Brozna JP; Ward PA
    J Clin Invest; 1975 Sep; 56(3):616-23. PubMed ID: 239965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic proteins of human granulocytes. VI. Effects on the complement system and mediation of chemotactic activity.
    Venge P; Olsson I
    J Immunol; 1975 Dec; 115(6):1505-8. PubMed ID: 1184964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
    Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
    J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two distinct chemotactic factor inactivators in human serum.
    Till G; Ward PA
    J Immunol; 1975 Feb; 114(2 pt 2):843-7. PubMed ID: 46254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
    Muhlfelder TW; Niemetz J; Kreutzer D; Beebe D; Ward PA; Rosenfeld SI
    J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
    Orr FW; Delikatny EJ; Mokashi S; Krepart GV; Stiver HG
    Am J Pathol; 1983 Jan; 110(1):41-7. PubMed ID: 6185003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a novel C5 inhibitor (K-76 COONa) on tumor cell chemotaxis.
    Bumpers HL; Baum J
    J Lab Clin Med; 1983 Sep; 102(3):421-7. PubMed ID: 6886523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
    Desai U; Dickey B; Varani J; Kreutzer DL
    J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the protease activity in the chemotactic factor inactivator.
    Ward PA; Ozols J
    J Clin Invest; 1976 Jul; 58(1):123-9. PubMed ID: 6489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A unique complement derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4128-32. PubMed ID: 172896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of passage, growth phase, and heterogeneity of a tumor cell population on tumor cell chemotaxis.
    Oda D; Orr FW
    Invasion Metastasis; 1984; 4(4):189-97. PubMed ID: 6533092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotactic responses of normal human basophils to C5a and to lymphocyte-derived chemotactic factor.
    Lett-Brown MA; Boetcher DA; Leonard EJ
    J Immunol; 1976 Jul; 117(1):246-52. PubMed ID: 932427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory dysfunction in leukotaxis.
    Ward PA; Johnson KJ; Kreutzer DL
    Am J Pathol; 1977 Sep; 88(3):701-10. PubMed ID: 142429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotactic factor for tumor cells derived from the C5a fragment of complement component C5.
    Orr W; Phan SH; Varani J; Ward PA; Kreutzer DL; Webster RO; Henson PM
    Proc Natl Acad Sci U S A; 1979 Apr; 76(4):1986-9. PubMed ID: 287038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.